Literature DB >> 6231950

Modulation of the actin-activated adenosinetriphosphatase activity of myosin by tropomyosin from vascular and gizzard smooth muscles.

M Yamaguchi, A Ver, A Carlos, J C Seidel.   

Abstract

Tropomyosins from bovine aorta and pulmonary artery exhibit identical electrophoretic patterns in sodium dodecyl sulfate but differ from tropomyosins of either chicken gizzard or rabbit skeletal muscle. Each of the four tropomyosins binds readily to skeletal muscle F-actin as indicated by their sedimentation with actin and by their ability to maximally stimulate or inhibit actin-activated ATPase activity at a molar ratio of one tropomyosin per seven actin monomers. Smooth and skeletal muscle tropomyosins differ in their effects on activity of skeletal myosin or heavy meromyosin (HMM); the former can enhance activity under conditions in which the latter inhibits. Gizzard and arterial tropomyosins are usually equally effective in stimulating ATPase activity of skeletal acto-HMM, but at high concentrations of Mg2+ gizzard tropomyosin is more effective, a result that cannot be attributed to differences in the binding of the two tropomyosins to F-actin. The effects of tropomyosin also depend on the type of myosin; tropomyosin enhances activity of gizzard myosin under conditions in which it inhibits that of skeletal myosin. Increasing the pH or the Mg2+ concentration can reverse the effect of tropomyosin on actin-stimulated ATPase activity of skeletal HMM from activation to inhibition, but this reversal is not found with gizzard myosin. Activity in the absence of tropomyosin is independent of pH, and the loss of activation with increasing pH is not accompanied by loss of binding of tropomyosin to actin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231950     DOI: 10.1021/bi00299a029

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Tropomyosin variants describe distinct functional subcellular domains in differentiated vascular smooth muscle cells.

Authors:  Cynthia Gallant; Sarah Appel; Philip Graceffa; Paul Leavis; Jim Jung-Ching Lin; Peter W Gunning; Galina Schevzov; Christine Chaponnier; Jon DeGnore; William Lehman; Kathleen G Morgan
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

2.  Structural variations in actins. Biochemical and immunological tools for probing the structure of rabbit skeletal-muscle and bovine aortic actins.

Authors:  J C Cavadore; C Roustan; Y Benyamin; M Boyer; J Haiech
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

3.  Effects of hypoxia on high-energy phosphagen content, energy metabolism and isometric force in guinea-pig taenia caeci.

Authors:  Y Ishida; R J Paul
Journal:  J Physiol       Date:  1990-05       Impact factor: 5.182

Review 4.  Polymorphism in tropomyosin structure and function.

Authors:  Miro Janco; Worawit Suphamungmee; Xiaochuan Li; William Lehman; Sherwin S Lehrer; Michael A Geeves
Journal:  J Muscle Res Cell Motil       Date:  2013-07-07       Impact factor: 2.698

Review 5.  The thin filaments of smooth muscles.

Authors:  S B Marston; C W Smith
Journal:  J Muscle Res Cell Motil       Date:  1985-12       Impact factor: 2.698

6.  Relationship between alternatively spliced exons and functional domains in tropomyosin.

Authors:  Y J Cho; S E Hitchcock-DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  In vitro and in vivo characterization of four fibroblast tropomyosins produced in bacteria: TM-2, TM-3, TM-5a, and TM-5b are co-localized in interphase fibroblasts.

Authors:  M F Pittenger; D M Helfman
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

8.  Fission yeast tropomyosin specifies directed transport of myosin-V along actin cables.

Authors:  Joseph E Clayton; Luther W Pollard; Maria Sckolnick; Carol S Bookwalter; Alex R Hodges; Kathleen M Trybus; Matthew Lord
Journal:  Mol Biol Cell       Date:  2013-11-06       Impact factor: 4.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.